[{"Assets_0_Q3_USD":110893000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":2253000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":2243000000.0,"StockholdersEquityConverted_0_Q3_USD":37284000000.0,"StockholdersEquity_0_Q3_USD":37213000000.0,"RevenuesConverted_1_Q3_USD":11624000000.0,"RevenuesConverted_3_Q3_USD":34400000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":2219000000.0,"NetIncomeLossConverted_1_Q3_USD":1546000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":12150000000.0,"EarningsPerShareDiluted_3_Q3_USD":2.05,"EarningsPerShareDiluted_1_Q3_USD":0.69,"EarningsPerShareBasic_3_Q3_USD":2.08,"EarningsPerShareBasic_1_Q3_USD":0.7,"CommonStockDividendsPerShareDeclared_1_Q3_USD":0.49,"NetIncomeLossConverted_3_Q3_USD":4622000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":2227000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20211027"}]